Du, Wenwen
Liu, Ping
Xu, Wei
Funding for this research was provided by:
National Natural Science Foundation of China (72074220, 72074220)
Article History
Received: 3 April 2022
Revised: 18 September 2022
Accepted: 16 October 2022
First Online: 16 November 2022
Declarations
:
: All methods in our study were carried out in accordance with the Declaration of Helsinki. Nanjing Healthcare Security Administration and China Pharmaceutical University gave approval for this study. In addition, this study does not include any information that could potentially identify an individual and we signed an agreement concerning data usage with Nanjing Healthcare Security Administration before we carried out this study. On these basis, all participants gave informed consent.
: Not applicable.
: The authors declare that they have no competing interests.